Viewing Study NCT05022394


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-05-23 @ 9:56 AM
Study NCT ID: NCT05022394
Status: WITHDRAWN
Last Update Posted: 2022-05-27
First Post: 2020-04-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study
Sponsor:
Organization: